An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
Clinical trial NCT02394834 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02394834
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2015-05-29
- Primary completion
- 2027-09-30
- Enrollment
- 757
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.